infectious diseases
Pneumococcal Vaccine
Indications for Pneumococcal Vaccine
For both adult age groups, the dose of PPSV23 should follow the dose of PCV15 by at least 1 year. A minimum interval of 8 weeks between PCV15 and PPSV23 can be considered for adults with an immunocompromising condition, cochlear implant, or cerebrospinal fluid (CSF) leak. Also, for those who have previously received a dose of pneumococcal vaccine, see detailed recommendations regarding further pneumococcal vaccine dosing at CDC: Pneumococcal Vaccination: Summary of Who and When to Vaccinate and CDC: Adult Immunization Schedule by Age.